A phase II study of gemcitabine and docetaxel combination in relapsed metastatic or unresectable locally advanced synovial sarcoma

Synovial sarcoma (SS) is one of the commonest non-rhabdomyosarcoma soft tissue sarcoma with limited treatment options in the relapsed and advanced settings. The combination of gemcitabine and docetaxel has demonstrated its role predominantly in leiomyosarcoma and pleomorphic sarcomas but has not bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Tansir, Ghazal, Rastogi, Sameer, Kumar, Akash, Barwad, Adarsh, Mridha, Asit R., Dhamija, Ekta, Shamim, Shamim A., Bhatnagar, Sushma, Bhoriwal, Sandeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329387/
https://www.ncbi.nlm.nih.gov/pubmed/37422615
http://dx.doi.org/10.1186/s12885-023-11099-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329387/
https://www.ncbi.nlm.nih.gov/pubmed/37422615
http://dx.doi.org/10.1186/s12885-023-11099-4

Ejemplares similares